Exagen XGN
NASDAQ XGN
$7.53 -0.14 (-1.83%)
As of: Aug 27, 2026 · 3:59 PM EDT

Exagen (XGN) Deferred Taxes (2020 - 2021)

Exagen's (XGN) quarterly Deferred Taxes came in at $148000.0 in Q4 2021, up 1245.45% YoY from $11000.0 in Q4 2020, and up 1245.45% on a QoQ basis from $11000.0 in Q4 2020.

Exagen (XGN) Deferred Taxes (2020 - 2021) Analysis & Trends

Exagen (XGN) has 2 years of Deferred Taxes data on file, last reported at $148000.0 in Q4 2021.

  • Quarterly Deferred Taxes rose 1245.45% year-over-year to $148000.0 in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $148000.0 (up 239.62% YoY) and the FY2022 annual result came in at -$306000.0, down 306.76% from the prior year.
  • Deferred Taxes climbed to $148000.0 in Q4 2021, from $11000.0 in the prior quarter.
  • In the past five years, Deferred Taxes ranged from a high of $148000.0 in Q4 2021 to a low of -$117000.0 in Q1 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Thermo Fisher Scientific 234.15 Bn 230.09 Bn 8.34 Bn -208.00 Mn
2 Danaher 152.10 Bn 147.75 Bn 3.61 Bn -
3 Natera 48.48 Bn 47.38 Bn 486.15 Mn -
4 Agilent Technologies 44.35 Bn 42.55 Bn 990.00 Mn 32.00 Mn
5 Iqvia Holdings 43.68 Bn 41.60 Bn 1.44 Bn -36.00 Mn
6 Idexx Laboratories 43.02 Bn 42.83 Bn 779.09 Mn 6.54 Mn
7 Illumina 34.39 Bn 33.22 Bn 770.00 Mn -21.00 Mn
8 Mettler Toledo International 28.29 Bn 28.24 Bn 650.22 Mn 1.82 Mn
9 Labcorp Holdings 27.51 Bn 27.37 Bn 1.11 Bn -24.40 Mn
10 Exagen 181.48 Mn 156.88 Mn 12.22 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2021 148,000.00
Dec 31, 2020 11,000.00
Mar 31, 2020 -117,000.00